Comment on ‘Effects of injectable progestogen contraception versus the copper intrauterine device on HIV acquisition: sub-study of a pragmatic randomised controlled trial’
Open Access
- 29 July 2017
- journal article
- letter
- Published by BMJ in BMJ Sexual & Reproductive Health
- Vol. 43 (4), 342
- https://doi.org/10.1136/jfprhc-2017-101827
Abstract
No abstract availableFunding Information
- National Institute of Child Health and Human Development
This publication has 5 references indexed in Scilit:
- Effects of injectable progestogen contraception versus the copper intrauterine device on HIV acquisition: sub-study of a pragmatic randomised controlled trialBMJ Sexual & Reproductive Health, 2017
- HIV and Hormonal Contraception: Bench and BedsideJAIDS Journal of Acquired Immune Deficiency Syndromes, 2017
- Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infectionMucosal Immunology, 2016
- Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studiesThe Lancet Infectious Diseases, 2015
- Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort studyThe Lancet Infectious Diseases, 2012